Sean Lee

Stock Analyst at HC Wainwright & Co.

(1.59)
# 1480
Out of 5,240 analysts
96
Total ratings
37.29%
Success rate
16.98%
Average return
Main Sectors:
14 Stocks
Name Action Price Target Current % Upside Ratings Updated
Corvus Pharma
Reiterates: Buy
11 11
5.1 115.69% 2 Jan 14, 2025
Alphatec Holdings
Reiterates: Buy
20 20
11.08 80.51% 11 Jan 14, 2025
Verastem
Reiterates: Buy
7 7
5.05 38.61% 12 Dec 19, 2024
Plus Therapeutics
Reiterates: Buy
8
1.17 583.76% 10 Nov 26, 2024
Myomo
Reiterates: Buy
8 8
6.08 23.36% 4 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 22
24.9 -11.65% 8 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
1 1
1.04 -3.85% 11 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
1 5
n/a n/a 4 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
4 1
n/a n/a 14 Oct 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
1.51 1224.5% 4 Jul 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 6
2.56 134.38% 7 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5
n/a n/a 7 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
1.15 2508.7% 1 Dec 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Mar 19, 2021